Health Care Equipment & Services

Veeva Systems faces a mixed week: JPMorgan Healthcare Conference boost, but Goldman Sachs downgrade over AI competition and valuation concerns—can the cloud‑native life‑sciences leader sustain growth?

Integer Holdings faces securities fraud, fiduciary breach claims, and a class‑action suit—discover what investors must know and deadlines for 2026.

RHOEN‑KLINIKUM AG reports Q1 profit decline amid fluctuating shares—yet its wide German health‑care network and diverse services suggest resilience and future growth potential.

Beyond Air’s $32 M NeuroNOS sale sparks a 165 % stock spike, funding its respiratory focus while eyeing lucrative autism therapy—an enticing, volatile biotech play.

CVS Health’s new $91 target from Bernstein shows bullish outlook amid insider‑trading probe—explore how its diversified pharmacy‑benefit model drives future growth.

TransMedics Group expands its transplant therapy leadership by moving into Assembly Innovation Park, securing 498,000 sq ft of state‑of‑the‑art biotech space to accelerate research, manufacturing, and investor engagement.

NeuroPace reports 25% revenue growth in FY2025, with 2026 guidance projecting 20‑22% core RNS revenue growth and a strong market‑adoption outlook.

Discover how Carl Zeiss Meditec leads in ophthalmology tech and market trends—stock insights, global reach, and eye‑care innovation.

Medical Care Technologies Inc. is pioneering AI‑powered pediatric centers in China, spotlighted by a $50k Jordan jersey test that won $4.5M—yet its tiny cap and volatile shares show investor caution.

NeoGenomics forecasts $190 M Q4 2025 revenue and $727 M yearly, while a CFO transition bolsters its precision‑medicine growth momentum.